Invention Grant
- Patent Title: PDE10a inhibitors for the treatment of type II diabetes
- Patent Title (中): 用于治疗II型糖尿病的PDE10a抑制剂
-
Application No.: US14299512Application Date: 2014-06-09
-
Publication No.: US09249163B2Publication Date: 2016-02-02
- Inventor: Mark R. Player , Sanath K. Meegalla , Carl R. Illig , Jinsheng Chen , Kenneth J. Wilson , Yu-Kai Lee , Daniel J. Parks , Hui Huang , Sharmila Patel , Tianbao Lu
- Applicant: Janssen Pharmaceutica, NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV.
- Current Assignee: JANSSEN PHARMACEUTICA NV.
- Current Assignee Address: BE Beerse
- Agency: Roberts Mlotkowski Safran & Cole, P.C.
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D487/04
Abstract:
Disclosed are compounds, compositions and methods for treating Type II diabetes and other disorders affected by activity of the enzyme PDE10a. Such compounds are represented by Formula (I) below, wherein R1, R2, L and Q are defined herein.
Public/Granted literature
- US20140364414A1 PDE 10a Inhibitors for the Treatment of Type II Diabetes Public/Granted day:2014-12-11
Information query
